57 results about "Blood circulation disorder" patented technology

A device for treating wounds on an individual is disclosed. The device includes a flexible foam, a treatment suitable for treating the wound placed in relative proximity to the foam, and a flexible fabric with recoverable properties substantially circumferencing the wound and the treated foam. The flexible fabric maintains the treated foam in substantial proximity to the wound to allow the treatment to treat the wound. A bandage suitable for treating wounds on an exterior limb is disclosed. The bandage includes a butterfly shaped flexible fabric, at least one Hook and loop material type fastener attachment located on the edge of the butterfly shaped flexible fabric, at least two foam layers located axially in the center of the butterfly shaped flexible fabric, and a medication suitable for treating the wound proximately located with respect to at least a first of the at least two foam layers. The butterfly shaped flexible fabric is suitable to be wrapped around the limb and fastened using the at least one Hook and loop material type fastener attachment, and the wrapped fabric maintains the at least two foam layers in proximate location with the wound such that the medication is located appropriately with the wound to provide treatment.

A device is provided for assessing impairment of blood circulation in a patient, such as that in perfusion failure, by measurement of blood flow adjacent a mucosal surface accessible by a mouth or nose and connecting with the gastrointestinal tract or upper respiratory / digestive tract of a patient. The device includes a blood-flow sensor adapted to be positioned adjacent a mucosal surface with a patient's body and measuring blood flow in adjacent tissue and a PCO.sub.2 sensor adapted to be positioned adjacent the mucosal surface and measuring PCO.sub.2. In addition a pH sensor may be used in combination with the blood flow determination. A method of detecting perfusion failure is also disclosed. The method includes utilizing blood-flow measurements in conjunction with a surface perfusion pressure index and / or an optical plethysmography index to more accurately assess perfusion failure. These measurements may also be supplement by taking measurements of pH, sublingual PCO.sub.2, and Sa O.sub.2. The invention affords rapid measurement and detection of perfusion failure.

A medical diagnostic method, system and related equipment particularly adapted to diagnose disorders of the blood circulation serving the head and neck, and especially the brain. A preferred use of the system is early, rapid, accurate, diagnosis of stroke, especially whether the stroke is due to blockage of a blood vessel or leakage from the blood vessel.

This invention provides safflower uranidin prepd. from the Chinese herb medicine-safflower which isu sed for promoting blood circulation and removing blood disturbance, and the prepn. method and usage therefor. Said safflower uranidin is tested by high efficiency liquid phase chromatography with its content of 70-99.6%. It can be used for treating and preventing various kinds of diseases, such as cardiovascular disease, cerebrovascular disease and other blood circulation disturbance disease.

The invention discloses an acer truncatum leaves health bagged tea, which comprises acer truncatum leaves, plateau greenleaf tea and semen cassiae, and is prepared through the steps of washing, spreading out for drying, water removing with vapor, kneading, drying, mixing and grinding, granulating, bagging, packaging and the like. By utilizing active substances which are rich in flavone, chlorogenic acid, tannin, cardiac glycosides and the like, health pharmacological active ingredients are not damaged, and the acer truncatum leaves health bagged tea can be used for treating and preventing coronary heart disease, angina pectoris, blood circulation disabled diseases and cardiovascular diseases and has actions of virus resistance, deflammation, cholagogue, removal of free radical of the human body, removal of liver heat, improvement of eyesight and the like.

The present invention provides an agent for improving mental disorders due to cerebral dysfunction and an agent for inhibiting vascular hyperpermeability each containing a hepatocyte growth factor. The agent for improving mental disorders according to the present invention is useful in improving mental disorders, particularly decline in learning and memory function, due to cerebral dysfunction occurred in blood circulation disorders in the brain (for example, cerebral infarction, cerebral hemorrhage, lacunar stroke, Biswanger's disease, cerebral thrombosis, subarachnoid hemorrhage, cerebrovascular moyamoya disease, carotid cerebral arterial fibrous muscular plasia, cerebral arterial sclerosis, internal carotid artery occlusion, hypertensive encephalopathy, cerebral edema, etc.) and neurodegenerative disorders (for example, multiple sclerosis, Parkinson's disease, Parkinson'syndrome, Huntington's chorea, cerebrovascular dementia and Alzheimer dementia), epilepsy, head injury, etc. The agent for inhibiting vascular hyperpermeability according to the present invention is efficacious to blood hyperpermeability in the brain due to blood circulation disorders in the brain (for example, cerebral infarction, cerebral hemorrhage, lacunar stroke, Biswanger's disease, cerebral thrombosis, subarachnoid hemorrhage, cerebrovascular moyamoya disease, carotid cerebral arterial fibrous muscular plasia, cerebral arterial sclerosis, internal carotid artery occlusion, hypertensive encephalopathy, cerebral edema, etc.), blood leakage, edema, subcutaneous hemorrhage and bleeding tendency due to vascular hyperpermeability in various tissues (including internal organs).

The invention discloses a WiFi upper arm type intelligent electronic sphygmomanometer. The WiFi upper arm type intelligent electronic sphygmomanometer comprises an electronic sphygmomanometer body, an air guide tube and an arm strap, wherein the electronic sphygmomanometer body comprises a shell; a display, a power key, a start / stop key, a storage key, a reading key, a first air guide nozzle and a loudspeaker are arranged on the outer surface of the shell; a functional circuit module is arranged inside the shell; a traction section, a hook surface, a loop surface, a metal ring and an indicating icon are arranged on the outer surface of the arm strap; an air bag is arranged inside the arm strap; a second air guide nozzle is arranged at the edge of the air bag; one end of the air guide tube is connected with the electronic sphygmomanometer body through the first air guide nozzle; and the other end of the air guide tube is connected with the arm strap through the second air guide nozzle. The invention further discloses a using method of the WiFi upper arm type intelligent electronic sphygmomanometer. The WiFi upper arm type intelligent electronic sphygmomanometer has the advantages of simplicity in operation, accurate measurement, automation and intelligence, and is quite suitable for patients suffering from disturbance of blood circulation and old people.

The invention provides novel hydroxysafflor yellow A divalent medicinal salt compounds shown as a formula (I), especially a calcium salt of hydroxysafflor yellow A and a magnesium salt of the hydroxysafflor yellow A which are single compounds, and a producing method and medicinal uses of the salt compounds. A natural medicine material safflower is adopted as a raw material. Carthamin yellow is converted into a hydroxysafflor yellow A acid form through a strong-acid H-type cation exchange resin. Then by adjusting a pH value, the hydroxysafflor yellow A is converted into the hydroxysafflor yellow A divalent medicinal salt single compounds. The purity of the compounds can be higher than 98.5%. Compared with the hydroxysafflor yellow A, the compounds are safer, more effective, more stable and more controllable for treatment of blood circulation disturbance diseases such as anti-platelet aggregation, coronary diseases, angina and acute cerebral ischemia, and have better water solubility and human body tolerance. R is defined in the specification.

The invention provides a stretcher constraining quilt, comprising two strip-type constraining quit bodies, one end of each constraining quilt body is connected with the side face of a stretcher bed by a zipper, the other end of each constraining quilt body can be mutually zipped up together to form constraint to a patient, multiple zipper tooth structures are arranged at a top edge of the outside surface of each constraining quilt body along the vertical direction, and the degree of tightness of the constraining quilt is adjusted conveniently. The stretcher constraining quilt can be filled with cotton fibre or is provided with air holes so as to meet the demand of use in winter and summer, and the humanistic care can be embodied, by using the constraining quilt, when an irritable and unconscious patient is transferred, the occurrence of the situations such as falling out of bed, crush injury, scratch, skin breakage caused by rub, disturbance of blood circulation and the like can be avoided, and discomfort of the patient and the burden of a stretcher bearer can be relieved.

The invention discloses an intensive care device for ICUs (Intensive Care Unit), which comprises a bedstead, a supporting pole is fixedly connected to the left side of the bedstead, hooks are fixedlyconnected to the surface, which is close to the top, of the supporting pole, a bed board is fixedly connected to the internal wall, which is closed to the top, of the bedstead, a back board is turnably connected to the left side of the bed board through a shaft, the surface of the back board is movably connected to the internal wall of the bedstead, and a bottom board is fixedly connected to the surface, which is close to the bottom, of the bedstead. Through the cooperation between the structures, the invention solves the following problems: in the process of actual use, because a patient lieson the bed for a long time, local compression can easily lead to blood circulation disorder, bringing discomfort to the patient, moreover, the conventional bed can hardly be adjusted to multiple angles, and as a result, more comfortable sitting and lying experience can hardly be brought to the patient; and furthermore, because the conventional bed can hardly support various monitoring devices aswell, detection devices cannot be conveniently carried as the patient is moved, bringing inconvenience to the monitoring of the patient.

The invention provides a suitable type non-invasive orthopaedic traction device, and belongs to the technical field of orthopaedic medical equipment. The suitable type non-invasive orthopaedic traction device is used for upper and lower limb traction. According to the technical scheme, rectangular boards of a vertical traction plate and a horizontal traction plate of the device are bent to the two sides in the length direction to form semicircle arcs, one end of the vertical traction plate is perpendicularly connected with one end of the horizontal traction plate, the semicircle arc-shaped protruding boards of the vertical traction plate and the horizontal traction plate are opposite to each other, the curvature of arcs of the semicircle arc-shaped boards of the vertical traction plate and the horizontal traction plate are suitable for the curvature of the circular arc degree of the surface of limbs subjected traction, two cuffs are nylon hook-and-loop fastener straps, one end of one cuff and one end of the other cuff are connected to the edges of the boards of the vertical traction plate and the horizontal traction plate respectively, one end of a traction belt is arranged on the lower portion of the vertical traction plate in a sleeving mode, and the traction belt is connected with the traction device. The suitable type non-invasive orthopaedic traction device has the advantages of being simple in structure, convenient to use, noninvasive and uniform in compression, disturbance of blood circulation can be avoided, and the problem that Kirschner wires or Steinmann pins are difficult to take out is thoroughly solved.

A hydroxysafflor yellow A sodium compound as shown in a formula (I) and preparation as well as medicinal application thereof are provided. According to the present invention, the safflower is utilized as a raw material. A monomer pharmaceutical compound, the hydroxysafflor yellow A sodium, is obtained by sufficient processes, and a purity thereof is surely above 98.5%. Therefore, the hydroxysafflor yellow A sodium is a monomer compound, which is safer, more effective, more stable and more controllable than hydroxysafflor yellow A, for treating blood circulation disorders such as platelet aggregation, coronary heart disease, angina pectoris and acute cerebral ischemia. Furthermore, the hydroxysafflor yellow A sodium has sufficient solubility and human tolerance.

The invention discloses application of a sambucus chinensis extract in preparing a medicine for treating brain blood circulation disturbance. The brain blood circulation disturbance refers to cerebral apoplexy. The sambucus chinensis extract is capable of reducing neurotoxicity caused by glutamic acid, reducing cortical neuron damage caused by oxygen-glucose deprivation, increasing the activity of glutathione peroxidase and superoxide disumtase in cortical neuronal cells and brain tissues and reducing the volume of cerebral ischemia infarction after cerebral apoplexy.

The traditional Chinese medicine particulate preparation has the recipe comprising rhinoceros horn, amber, nacre, earthworm, red sage and other 12 kinds of Chinese medicinal materials and is preparedthrough washing with pure water, stoving, concentration and granulating. It can cure cardiac and cerebral vascular diseases radically through improving heart, liver and kidney functions, promoting blood, circulation and improving blood supply. It can cure hypertension, cerebral thrombosis, cerebral apoplexy, cerebral infarction and cerebral diseases with stable curative effect. It can recover andregenerate failed internal organs and blood vessels, and has obivous anti-senility, beautifying and immunity raising effects.

An encephalic blood circulation disturbance nondestructive detection system based on network topological analysis comprises a carotid artery measuring unit, a lower limb artery measuring unit, a signal collection processing control unit and an analysis host, the encephalic blood circulation disturbance nondestructive system is free from directly detecting the brain, only the pulse waveform on the surface of the lower limbs and the neck is measured, the encephalic blood circulation disturbance can be indirectly judged through corresponding equivalent conversion and formula calculation as well as contrast to the threshold value, and the limit of the existing detection device that the existing peripheral blood vessel measuring technology cannot be applied to the judgment of the encephalic blood circulation disturbance can be overcome.